Apart from AIMed Europe 2019, which will embark in a month’s time in London, AIMed is hosting two AIMed Breakfast Briefing sessions on either end of the world, both of which taking place on the same day: Friday, 16 August 2019. 

Breakfast Briefing 1: Effectively analyzing rare pediatric diseases by using the latest innovations in genomic AI technology

Venue: Innovation Institute. 620 Newport Center Drive, Suite 700, Newport Beach, CA 92660, US 

Time: 08:00 – 10:00 (PDT) 


  • Dr. Anthony Chang, AIMed Founder and Chairman; Pediatric Cardiologist; Chief Intelligence and Innovation Officer, Children’s Hospital of Orange County (CHOC). 
  • Dr. Spyro Mousses, Executive Scientific Advisor, Children’s Hospital of Orange County (CHOC) 
  • Emily Paul, Head of Subject Matter Experts, SOPHiA GENETICS 

Please register your interest here.

Breakfast Briefing 2: First AIMed Breakfast Briefing in Australia

Venue: PwC Sydney, Level 17, One International Towers, Watermans Quay, Barangaroo, NSW 2000 

Time: 07:00 – 09:30 (AEST) 


  • Dr. Anthony Chang, AIMed Founder and Chairman; Pediatric Cardiologist; Chief Intelligence and Innovation Officer, Children’s Hospital of Orange County (CHOC). 
  • Professor Enrico Coiera, Director, Centre for Health Informatics, Australian Institute of Health Innovation, Macquarie University 
  • Dr. Haroon Kasim, Medical Hospitalist, Hornsby Ku-ring-gai Hospital
  • Dr. M. Talat Uppal, Obstetrician & Gynecologist; Visiting Medical Officer, Northern Beaches Hospital; Visiting Medical Officer, Hornsby Ku-ring gai Hospital; Clinical Senior Lecturer, University of Sydney 
  • Dr. Michael Costello, Health Specialist

Please register your interest here

The role of genomic AI technology 

As the title suggests, one of the upcoming AIMed Breakfast Briefing focuses on genomic artificial intelligence (AI) technology. Technology not only facilitated our study of a complete set of genes within an organism but also the onset and progress of a disease within a particular genetic makeup. This allows us to determine the best possible treatment or care plan for an individual patient. 

Earlier, AIMed spoke with SOPHiA GENETICS’ Senior Vice-President Radiomics and renown mathematician, Thierry Colin to find out more about how genomic AI technology and a combination of genomics and radiomics could provide a new kind of quantitative information to better assist oncologists in the treatment of cancer patients (you may read the full interview on AIMed Magazine Volume 2, Issue 2: The Cardiology & Radiology Issue) . 

Once again, experts from SOPHiA GENETICS, together with AIMed, will detail how the same technology could potentially benefit children with rare forms of medical conditions and challenges of data-driven medicine. 

AIMed Breakfast Briefing in Australia 

AIMed announced in May it’s partnering with Best Case Scenario (BCS), a leading event management company to launch AIMed Australia this November. The partnership is an extension of AIMed’s vision: to bring about a revolution that embraces a new paradigm of medicine and healthcare propelled by AI and related new technologies. 

Leading to the AIMed Australia conference are a series of seminars and workshops, to provide our audience an overview of the local AI landscape, understand the challenges and benefits of deploying AI in the local healthcare system, and connect experts from various sectors. 

In this particular Breakfast Briefing session, three Australian clinicians will be presenting their work on using AI and related innovations to solve practical challenges that they experienced regularly. AIMed will then select the winning solution to be showcased at AIMed Australia this November. 

Whether you are joining us physically or digitally (via live-streaming), do follow us on TwitterInstagramFacebookLinkedIn, and YouTube for more updates. Please also visit our main events page to indicate your interests in future events or to revisit some of our recent webinars and breakfast briefing sessions. We look forward to meeting you in one of our events in the near future. 

Author Bio
synthetic gene empathy chinese artificial intelligence data medicine healthcare ai

Hazel Tang

A science writer with data background and an interest in the current affair, culture, and arts; a no-med from an (almost) all-med family. Follow on Twitter.